These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 10516989

  • 1. Oral phosphate binders: phosphate binding capacity of iron (III) hydroxide complexes containing saccharides and their effect on the urinary excretion of calcium and phosphate in rats.
    Yamaguchi T, Baxter JG, Maebashi N, Asano T.
    Ren Fail; 1999 Sep; 21(5):453-68. PubMed ID: 10516989
    [Abstract] [Full Text] [Related]

  • 2. Effect of iron(III) chitosan intake on the reduction of serum phosphorus in rats.
    Baxter J, Shimizu F, Takiguchi Y, Wada M, Yamaguchi T.
    J Pharm Pharmacol; 2000 Jul; 52(7):863-74. PubMed ID: 10933138
    [Abstract] [Full Text] [Related]

  • 3. Preclinical Pharmacokinetics, Pharmacodynamics and Safety of Sucroferric Oxyhydroxide.
    Cozzolino M, Funk F, Rakov V, Phan O, Teitelbaum I.
    Curr Drug Metab; 2014 Jul; 15(10):953-65. PubMed ID: 25658128
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of Phosphate Binding Capacities of PA21, A Novel Phosphate Binder, with those of other Phosphate Binders in vitro and in vivo.
    Yaguchi A, Yonekubo S, Maruyama I, Tatemichi S, Maruyama K, Kobayashi M.
    Drug Res (Stuttg); 2016 May; 66(5):262-9. PubMed ID: 26761712
    [Abstract] [Full Text] [Related]

  • 8. Stabilized polynuclear iron hydroxide is an efficient oral phosphate binder in uraemic patients.
    Hergesell O, Ritz E.
    Nephrol Dial Transplant; 1999 Apr; 14(4):863-7. PubMed ID: 10328460
    [Abstract] [Full Text] [Related]

  • 9. RenaGel, a novel calcium- and aluminium-free phosphate binder, inhibits phosphate absorption in normal volunteers.
    Burke SK, Slatopolsky EA, Goldberg DI.
    Nephrol Dial Transplant; 1997 Aug; 12(8):1640-4. PubMed ID: 9269642
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Iron kinetics following treatment with sucroferric oxyhydroxide or ferric citrate in healthy rats and models of anaemia, iron overload or inflammation.
    Floege J, Funk F, Ketteler M, Rastogi A, Walpen S, Covic AC, Sprague SM.
    Nephrol Dial Transplant; 2020 Jun 01; 35(6):946-954. PubMed ID: 32259248
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The Phosphate Binder Ferric Citrate and Mineral Metabolism and Inflammatory Markers in Maintenance Dialysis Patients: Results From Prespecified Analyses of a Randomized Clinical Trial.
    Van Buren PN, Lewis JB, Dwyer JP, Greene T, Middleton J, Sika M, Umanath K, Abraham JD, Arfeen SS, Bowline IG, Chernin G, Fadem SZ, Goral S, Koury M, Sinsakul MV, Weiner DE, Collaborative Study Group.
    Am J Kidney Dis; 2015 Sep 01; 66(3):479-88. PubMed ID: 25958079
    [Abstract] [Full Text] [Related]

  • 14. Cross-linked iron dextran is an efficient oral phosphate binder in the rat.
    Spengler K, Follmann H, Boos KS, Seidel D, von der Haar F, Elsner R, Maywald F.
    Nephrol Dial Transplant; 1996 May 01; 11(5):808-12. PubMed ID: 8671899
    [Abstract] [Full Text] [Related]

  • 15. The utility of the phosphate binder, ferric citrate hydrate (JTT-751), about phosphorus absorption-reducing effect in normal rats.
    Matsuo A, Iida A, Tanimoto M, Matsushita M, Miyamoto K.
    Ren Fail; 2014 Sep 01; 36(8):1291-7. PubMed ID: 24975675
    [Abstract] [Full Text] [Related]

  • 16. Influence of pH on in vitro disintegration of phosphate binders.
    Stamatakis MK, Alderman JM, Meyer-Stout PJ.
    Am J Kidney Dis; 1998 Nov 01; 32(5):808-12. PubMed ID: 9820451
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 01; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 20. Kinetic analysis of 52Fe-labelled iron(III) hydroxide-sucrose complex following bolus administration using positron emission tomography.
    Beshara S, Lundqvist H, Sundin J, Lubberink M, Tolmachev V, Valind S, Antoni G, Långström B, Danielson BG.
    Br J Haematol; 1999 Feb 01; 104(2):288-95. PubMed ID: 10050710
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.